Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment

BACKGROUND: Sorafenib is an oral drug that prolongs overall survival (OS) in patients with hepatocellular carcinoma. Adverse events, including hand-foot skin reaction (HFSR), lead to permanent sorafenib discontinuation. AIM: To clarify the association between interventions for adverse events and pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Masanori, Kamoshida, Toshiro, Araki, Masahiro, Ikegami, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409165/
https://www.ncbi.nlm.nih.gov/pubmed/34539142
http://dx.doi.org/10.3748/wjg.v27.i32.5424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409165/
https://www.ncbi.nlm.nih.gov/pubmed/34539142
http://dx.doi.org/10.3748/wjg.v27.i32.5424

Ejemplares similares